title: [Combination of in-situ hepatic split and portal ligation in patients with colorectal cancer and metastatic hepatic spread].
abstract: In up to 50% of patients, suffering colorectal cancer (CRC), a hepatic metastatic affection was revealed, in 20-34% of them the metastases have occurred synchroniously with primary tumor. The main problem in estimation of resectability of metastatic CRC (mCRC) is a possibility to preserve a sufficient volume of the organ parenchyma, because an acute hepatic insufficiency (AHI) constitute one of the main risk factors for occurrence of complications and mortality in early postoperative period after extended hemihepatectomy. The expediency of application in National Cancer Institute of the insitu hepatic split in conjunction with a portal ligation (ISHS-PL), elaborated by surgical group in Regensburg, was studied up. The results of treatment of mCRC, using ISHS-PL--in 3 patients and of a standard two-staged hepatic resection--in 3, were analyzed. Duration of a gap period between the ISHS-PL stages have constituted on average (10 +/- 1) days, and for a standard two-staged hepatic resection--(56 +/- 11.3) days (p = 0.001). The investigation results witness a safety of performance of the ISHS-PL in patients, suffering mCRC. Application of such a surgical tactics have permitted to reduce the risk of an AHI occurrence after performance of the extended hepatic resection in patients, suffering bilobar metastatic hepatic affection.
authors: I B
authors: IB
authors: Shchepotin
authors: O O
authors: OO
authors: Kolesnik
authors: A V
authors: AV
authors: Lukashenko
authors: A A
authors: AA
authors: Burlaka
authors: V V
authors: VV
authors: Pryĭmak
authors: O V
authors: OV
authors: Hanich
mesh_terms: D000230:Adenocarcinoma / Q000556:secondary / Q000601:surgery*; D003106:Colon / Q000473:pathology / Q000601:surgery; D015179:Colorectal Neoplasms / Q000473:pathology / Q000601:surgery*; D005260:Female; D006498:Hepatectomy / Q000009:adverse effects / Q000379:methods*; D048550:Hepatic Insufficiency / Q000209:etiology / Q000473:pathology / Q000517:prevention & control*; D006801:Humans; D007902:Length of Stay; D008026:Ligation / Q000379:methods; D008099:Liver / Q000473:pathology / Q000601:surgery; D008113:Liver Neoplasms / Q000556:secondary / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011169:Portal Vein / Q000601:surgery*; D016896:Treatment Outcome